• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Kibdelomycin 的全合成。

Total Synthesis of Kibdelomycin.

机构信息

Department of Chemistry, Scripps Research, 10550N. Torrey Pines Road, La Jolla, CA 92122, USA.

Department of Biology, Northeastern University, 360 Huntington Avenue, Boston, Ma 02115, USA.

出版信息

Angew Chem Int Ed Engl. 2022 Aug 8;61(32):e202206183. doi: 10.1002/anie.202206183. Epub 2022 Jul 6.

DOI:10.1002/anie.202206183
PMID:35704446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9357209/
Abstract

A modular total synthesis of kibdelomycin is disclosed that should enable structure-activity relationship (SAR) studies of this interesting class of antibiotics. The route uses simple building blocks and addresses lingering questions about its structural assignment and relationship to amycolamicin, a recently described natural product reported to have a similar structure. Initial antibacterial assays reveal that both C-22 epimers (the N-glycosidic linkage) of the natural product have similar activity while structurally truncated analogs lose activity.

摘要

本文公开了一种卷曲霉素的模块化全合成方法,这将有助于对这类新型抗生素进行结构-活性关系(SAR)研究。该路线使用了简单的起始原料,并解决了有关其结构确定以及与 recently described natural product reported to have a similar structure 的amycolamicin 的关系的遗留问题。初步的抗菌活性测试表明,天然产物的 C-22 差向异构体(N-糖苷键)具有相似的活性,而结构截短的类似物则失去了活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0955/9545773/299087a8158b/ANIE-61-0-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0955/9545773/55e27b71a1f0/ANIE-61-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0955/9545773/0ba193a8bac5/ANIE-61-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0955/9545773/bedadbdde609/ANIE-61-0-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0955/9545773/299087a8158b/ANIE-61-0-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0955/9545773/55e27b71a1f0/ANIE-61-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0955/9545773/0ba193a8bac5/ANIE-61-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0955/9545773/bedadbdde609/ANIE-61-0-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0955/9545773/299087a8158b/ANIE-61-0-g006.jpg

相似文献

1
Total Synthesis of Kibdelomycin.Kibdelomycin 的全合成。
Angew Chem Int Ed Engl. 2022 Aug 8;61(32):e202206183. doi: 10.1002/anie.202206183. Epub 2022 Jul 6.
2
Total Synthesis of the Potent and Broad-Spectrum Antibiotics Amycolamicin and Kibdelomycin.强效广谱抗生素艾米卡霉素和奇霉素的全合成。
J Am Chem Soc. 2021 Dec 22;143(50):21258-21263. doi: 10.1021/jacs.1c11477. Epub 2021 Dec 8.
3
Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus.通过在金黄色葡萄球菌中进行化学遗传学分析发现新型强效细菌II型拓扑异构酶抑制剂奇伯霉素。
Chem Biol. 2011 Aug 26;18(8):955-65. doi: 10.1016/j.chembiol.2011.06.011.
4
Discovery and development of kibdelomycin, a new class of broad-spectrum antibiotics targeting the clinically proven bacterial type II topoisomerase.新型广谱抗生素奇霉素的发现与开发,该抗生素靶向经临床验证的细菌II型拓扑异构酶。
Bioorg Med Chem. 2016 Dec 15;24(24):6291-6297. doi: 10.1016/j.bmc.2016.04.043. Epub 2016 Apr 22.
5
Kibdelomycin A, a congener of kibdelomycin, derivatives and their antibacterial activities.Kibdelomycin A,一种与 kibdelomycin 相关的同系物、衍生物及其抗菌活性。
Bioorg Med Chem Lett. 2012 Dec 1;22(23):7127-30. doi: 10.1016/j.bmcl.2012.09.071. Epub 2012 Oct 2.
6
Kibdelomycin is a bactericidal broad-spectrum aerobic antibacterial agent.奇霉素是一种具有杀菌作用的广谱需氧抗菌剂。
Antimicrob Agents Chemother. 2015;59(6):3474-81. doi: 10.1128/AAC.00382-15. Epub 2015 Apr 6.
7
Structures of kibdelomycin bound to Staphylococcus aureus GyrB and ParE showed a novel U-shaped binding mode.与金黄色葡萄球菌GyrB和ParE结合的奇霉素结构显示出一种新型的U形结合模式。
ACS Chem Biol. 2014 Sep 19;9(9):2023-31. doi: 10.1021/cb5001197. Epub 2014 Jul 3.
8
Establishing the Comprehensive Structure-Activity Relationship of the Natural Antibiotic Kibdelomycin/Amycolamicin.
Angew Chem Int Ed Engl. 2025 Jan 15;64(3):e202415439. doi: 10.1002/anie.202415439. Epub 2024 Nov 6.
9
Modular, Scalable Synthesis of Group A Streptogramin Antibiotics.A 组链球菌抗生素的模块化、可扩展合成。
J Am Chem Soc. 2017 Sep 27;139(38):13304-13307. doi: 10.1021/jacs.7b08577. Epub 2017 Sep 18.
10
Modular Chemical Synthesis of Streptogramin and Lankacidin Antibiotics.模块化化学合成链阳性菌素和兰卡菌素类抗生素。
Acc Chem Res. 2021 Apr 20;54(8):1891-1908. doi: 10.1021/acs.accounts.0c00894. Epub 2021 Apr 1.

引用本文的文献

1
Formal synthesis of kibdelomycin and derivatisation of amycolose glycosides.奇霉素的形式合成及枝动链霉菌糖苷的衍生化
Chem Sci. 2023 Mar 3;14(13):3562-3568. doi: 10.1039/d3sc00595j. eCollection 2023 Mar 29.

本文引用的文献

1
Total Synthesis of the Broad-Spectrum Antibiotic Amycolamicin.广谱抗生素阿霉素的全合成
J Am Chem Soc. 2022 Mar 30;144(12):5253-5257. doi: 10.1021/jacs.2c00647. Epub 2022 Mar 17.
2
Total Synthesis of the Potent and Broad-Spectrum Antibiotics Amycolamicin and Kibdelomycin.强效广谱抗生素艾米卡霉素和奇霉素的全合成。
J Am Chem Soc. 2021 Dec 22;143(50):21258-21263. doi: 10.1021/jacs.1c11477. Epub 2021 Dec 8.
3
Synthesis of the N-Acyl Amycolose Moiety of Amycolamicin and Its Methyl Glycosides.阿美霉素 N-酰基糖脂部分及其甲基糖苷的合成。
J Org Chem. 2019 Jun 7;84(11):7474-7479. doi: 10.1021/acs.joc.9b00650. Epub 2019 May 15.
4
Recent progress in the discovery and development of DNA gyrase B inhibitors.DNA 拓扑异构酶 B 抑制剂的发现和发展的最新进展。
Future Med Chem. 2018 May 1;10(10):1207-1227. doi: 10.4155/fmc-2017-0257. Epub 2018 May 22.
5
Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.新型抗菌化合物及其药物靶点——成功与挑战。
Curr Med Chem. 2017;24(18):1948-1982. doi: 10.2174/0929867323666161213102127.
6
Discovery and development of kibdelomycin, a new class of broad-spectrum antibiotics targeting the clinically proven bacterial type II topoisomerase.新型广谱抗生素奇霉素的发现与开发,该抗生素靶向经临床验证的细菌II型拓扑异构酶。
Bioorg Med Chem. 2016 Dec 15;24(24):6291-6297. doi: 10.1016/j.bmc.2016.04.043. Epub 2016 Apr 22.
7
Dual targeting DNA gyrase B (GyrB) and topoisomerse IV (ParE) inhibitors: A review.双靶点DNA促旋酶B(GyrB)和拓扑异构酶IV(ParE)抑制剂综述
Bioorg Chem. 2015 Oct;62:41-63. doi: 10.1016/j.bioorg.2015.07.004. Epub 2015 Jul 23.
8
Kibdelomycin is a bactericidal broad-spectrum aerobic antibacterial agent.奇霉素是一种具有杀菌作用的广谱需氧抗菌剂。
Antimicrob Agents Chemother. 2015;59(6):3474-81. doi: 10.1128/AAC.00382-15. Epub 2015 Apr 6.
9
Structures of kibdelomycin bound to Staphylococcus aureus GyrB and ParE showed a novel U-shaped binding mode.与金黄色葡萄球菌GyrB和ParE结合的奇霉素结构显示出一种新型的U形结合模式。
ACS Chem Biol. 2014 Sep 19;9(9):2023-31. doi: 10.1021/cb5001197. Epub 2014 Jul 3.
10
Exploring dual electrophiles in peptide-based proteasome inhibitors: carbonyls and epoxides.探索基于肽的蛋白酶体抑制剂中的双亲电试剂:羰基与环氧化物。
Org Biomol Chem. 2014 Aug 14;12(30):5710-8. doi: 10.1039/c4ob00893f. Epub 2014 Jun 26.